Daily non-political popular news in brief.

MMR, chicken pox vaccines work for preemies

Vaccines for measles-mumps-rubella and varicella, or chicken pox, are effective in extremely preterm infants, even though preemies' immune systems are not as developed as full-term babies. This confirms a long-held assumption by pediatricians and neonatologists across the country.

Read more »

Keywords: mmr, chicken, pox, vaccines, work, preemies, vaccine, preemy

« Previous | Next »

Similar news on "MMR, chicken pox vaccines work for preemies":

1. Smallpox outbreak: How long would it take for vaccines to protect people? Would it work?
   04-30-2007 · EurekAlert!
   In the event of a smallpox outbreak in the United States, how long would it take for a vaccine to start protecting Americans by stimulating an immune response? A new national study led by Saint Louis University School of Medicine will attempt to answer this question.
   Similar news · Read more »
   
2. The quest for an effective HIV vaccine presents new possibilities, challenges
   05-16-2007 · EurekAlert!
   A vaccine that prevents HIV infection remains an important goal in the fight against AIDS, but the current top HIV vaccine candidates may not work in this way, say scientists at NIAID. Rather, the first successful preventive HIV vaccines, if administered prior to HIV infection, may reduce HIV levels in the body, thereby delaying the progression to AIDS and the need to start antiretroviral drugs.
   Similar news · Read more »
   
3. New MUHC study adds more evidence to clear measles mumps rubella vaccine as a risk factor for autism
   10-17-2006 · EurekAlert!
   A new MUHC study provides conclusive evidence that the Measles Mumps Rubella vaccine is not associated with the development of autism spectrum disorders. The study, published in the scientific journal Pediatrics, reveals fundamental errors in previous molecular studies that falsely implicated the MMR vaccine as a risk factor for autism.
   Similar news · Read more »
   
4. Progress made in HIV vaccine development
   11-10-2006 · EurekAlert!
   Researchers have successfully tested two candidate vaccines that may eventually be used together to confer immunity against HIV infection. Their findings are published in the Dec. 15 issue of the Journal of Infectious Diseases, now available online.
   Similar news · Read more »
   
5. Cancer vaccines -- Taking a jab at cancer by stimulating the immune system
   04-17-2007 · EurekAlert!
   As the first FDA-approved cancer vaccine, designed to protect against human papillomavirus, has moved from scientific discussion to social debate, other vaccine studies are continuing to make progress. While HPV vaccine efforts had the "benefit" of a viral source for the disease, other researchers are developing vaccines for cancers that are not virally based, in an effort to coax the immune system into attacking cancerous cells.
   Similar news · Read more »
   
6. Bug-Zapper: A dose of radiation may help knock out malaria
   11-08-2007 · EurekAlert!
   Researchers at NIST used their expertise in radiation science to help a young company create weakened, harmless versions of malaria-causing parasites that, in turn, are being used to create a new type of vaccine that shows promise of being more effective than current malaria vaccines.
   Similar news · Read more »
   
7. Iowa State researchers look for smaller, cheaper, 1-dose vaccines
   01-15-2008 · EurekAlert!
   An Iowa State team of researchers is hoping to find a way to produce vaccines that work better, use smaller doses and require only one trip to the doctor's office.
   Similar news · Read more »
   
8. Updates on pandemic flu vaccine trials to be presented at 44th annual IDSA meeting
   10-12-2006 · EurekAlert!
   Preliminary results from clinical trials testing two different pandemic flu vaccine approaches -- one a prime-boost strategy using different subtypes of H5N1 vaccines, the other an H5N1 vaccine delivered into the skin rather than the muscle -- will be presented at the 44th Annual Meeting of the Infectious Diseases Society of America being held in Toronto on Oct. 12-15. The presentations are scheduled for a late-breaker session on Friday afternoon, Oct. 13.
   Similar news · Read more »
   
9. Who should receive vaccines and antiviral drugs in the event of a flu pandemic?
   10-16-2006 · EurekAlert!
   A new study in PLoS Medicine finds that 30 percent of nations have prioritized neither vaccine nor drugs in their pandemic influenza preparedness plans.
   Similar news · Read more »
   
10. Anthrax cellular entry point uncovered
    01-25-2008 · EurekAlert!
    Anthrax spores enter the cell through something called Mac-1, a receptor that sits on the surface of certain cells, according to a new study. Unraveling the anthrax-Mac-1 gateway will speed the development of new drugs and vaccines to fight or prevent infection, and advance the understanding of bacterial infection. The study was the work of microbiologists at the University of Alabama at Birmingham.
    Similar news · Read more »